Authors:
Byrd, JC
Murphy, T
Howard, RS
Lucas, MS
Goodrich, A
Park, K
Pearson, M
Waselenko, JK
Ling, G
Grever, MR
Grillo-Lopez, AJ
Rosenberg, J
Kunkel, L
Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164
Authors:
Flinn, IW
O'Donnell, PV
Goodrich, A
Vogelsang, G
Abrams, R
Noga, S
Marcellus, D
Borowitz, M
Jones, R
Ambinder, RF
Citation: Iw. Flinn et al., Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma, BIOL BLOOD, 6(6), 2000, pp. 628-632
Authors:
Byrd, JC
Grever, MR
Waselenko, JK
Willis, CR
Park, K
Goodrich, A
Lucas, MA
Shinn, C
Flinn, IW
Citation: Jc. Byrd et al., Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders, SEMIN ONCOL, 27(2), 2000, pp. 37-40